NCT07257393Not yet recruiting
Fall Risk Assessment in Parkinson's Disease Using Kinetikos Health
Validation of a Mobile Health Application for Fall Risk Assessment in Parkinson's Disease: A Comparative Study Before and After Dopaminergic Medication Adjustment
Source: ClinicalTrials.gov · Last updated 4 Dec 2025
Brief summary (registry, in English)
This is a single-center, prospective observational study aiming to validate the Kinetikos Health App for fall risk assessment in PD patients undergoing dopaminergic medication adjustments.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 20 Nov 2025
- Start date
- 1 Dec 2025
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- Taipei Medical University Shuang Ho Hospital
- Diseases
- Parkinson disease
- NCT number
- NCT07257393
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Dec 2025 to the primary completion date, 30 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Moderate-severe dementia;
Other
- Atypical/secondary parkinsonism;
- DBS/MRgFUS/neurosurgery within 6 months;
- Severe comorbidities limiting test
Who the study is looking for
- Age ≥20;
- PD diagnosis (MDS criteria);
- On levodopa monotherapy with motor fluctuations;
- Planned to start opicapone or safinamide;
- Consent provided.
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shuang Ho Hospital, Taipei Medical University Coordinator of this site? Confirm its status | New Taipei City | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.